Effects of Poloxamer 188 on the Assembly, Structure and Dissolution of Fibrin Clots

Summary

Poloxamer 188, N.F. (RheothRx^®), a nonionic block copolymer composed of 2 hydrophilic polyoxyethylene chains connected by a hydrophobic polyoxypropylene chain, normalizes the viscosity of whole blood high in soluble fibrin(ogen) complexes. Normalization may be via a poloxamer 188-induced decrease in fibrin(ogen)-red cell interaction. Our study examined the influences of poloxamer 188 on fibrin assembly and structure. Studies were performed in both purified and plasma systems with a poloxamer 188 concentration range of 0.1-20 mg/ml and specific clotting conditions (fibrinogen 1 mg/ml, thrombin 1 NIH u/ml, pH 7.4 [Tris 0.05 M], ionic strength 0.15 and calcium 5 mM). Fibrin assembly was accelerated in the presence of poloxamer 188. As poloxamer 188 concentration was increased from 0 to 8 mg/ml in plasma: a) the lag phase prior to initial turbidity rise decreased from 25 to <5 s; b) the final gel optical density (OD) increased from 0.65 to 1.28 and c) fiber size (mass/length ratio [ε]) increased from 4.3 to 12.6 × 10¹³ daltons/cm. Similar results were seen in the purified system with a poloxamer 188 concentration range of 0-8 mg/ml. OD increased from 0.26 to 0.51, and ε increased from 2.3 to 5.3 × 10¹³ daltons/cm. Above 8 mg/ml, precipitation of fibrinogen was noted in this system. Since large fibrin fibers tend to be degraded more rapidly, possible poloxamer mediated enhancement of r-tPA-mediated clot lysis was investigated. With r-tPA (70 lu/ml) present at the time of clotting, clot lysis in the presence of ploxamer 188 (8 mg/ml) was 50% complete at 1,600 s compared to 2,540 s for the control. Thus, poloxamer 188-induced alterations in fibrin structure and fibrin-cell interactions may explain some of this agent's interesting hemorrheologic and antithrombotic properties.

• References

• 1 Ferry JD, Morrison PR. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J Am Chem Soc 1947; 69: 388-99
• 2 Shulman S, Ferry JD, Tinoco I. The conversion of fibrinogen to fibrin. XII. Influence of pH, ionic strength and hexamethylene glycol concentration on the polymerization of fibrinogen. Arch Biochem Biophys 1953; 42: 245-56
• 3 Gabriel DA, Smith LA, Folds JD, Davis L, Cancelosi SE. The influence of immunoglobulin (IgG) on the assembly of fibrin gels. J Lab Clin Med 1983; 101: 545-52
• 4 Bale MD, Westrick LG, Mosher DF. Incorporation of thrombospondin into fibrin clots. J Biol Chem 1985; 260: 7502-8
• 5 Carr ME. Turbidimetric evaluation of albumin's impact on the structure of thrombin mediated fibrin gels. Haemostasis 1987; 17: 189-94
• 6 Carr ME, Gabriel DA, McDonagh J. Influence of factor XIII and fibronectin on fiber size in thrombin-induced fibrin gels. J Lab Clin Med 1987; 110: 747-52
• 7 Carr ME, Gabriel DA, Herion JC, Roberts HR. Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structure. J Lab Clin Med 1986; 107: 199-203
• 8 Carr ME, White GC, Gabriel DA. Platelet factor 4 enhances fibrin fiber polymerization. Thromb Res 1987; 45: 539-43
• 9 LeBoeuf RD, Gregg RR, Weigel PH, Fuller GM. Effects of hyalronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry 1987; 26: 6052-7
• 10 Jones M, Gabriel DA. Influence of the subendothelial basement membrane components on fibrin assembly. Evidence for a fibrin binding site on Type IV collagen. J Biol Chem 1988; 263: 7043-8
• 11 Carr ME, Powers PL. Effect of glycosaminoglycans on thrombin- and atroxin-induced fibrin assembly and structure. Thromb Haemostas 1989; 62: 1057-61
• 12 Carr ME, Gabriel DA, McDonagh J. Influence of calcium on the structure of reptilase and thrombin derived fibrin gels. Biochem J 1986; 239: 513-6
• 13 Shen LL, Hermans J, McDonagh RP, Carr ME. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res 1975; 6: 255-65
• 14 Marx G. Divalent cations induce protofibril gelation. Am J Hematol 1988; 27: 104-9
• 15 Carr ME, Gabriel DA. The effect of dextran 70 on the structure of plasma-derived fibrin gels. J Lab Clin Med 1980; 96: 985-93
• 16 Carr ME, Gabriel DA. Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 1980; 13: 1473-7
• 17 Carr ME. The effect of hydroxyethyl starch on the structure of thrombin and reptilase induced fibrin gels. J Lab Clin Med 1986; 108: 556-63
• 18 Carr ME, Hardin CL. Large fibrin fibers enhance urokinase-induced plasmin digestion of plasma clots. Blood 1987; 70 (Suppl 1) 400a
• 19 Hunter RL, Papadea C, Gallagher CJ, Finlayson DC, Check IJ. Increased whole blood viscosity during coronary artery bypass surgery – studies to evaluate the effects of soluble fibrin and poloxamer 188. Thromb Haemostas 1990; 63: 6-12
• 20 Colbassani HJ, Barrow DL, Sweeney KM, Bakay RAE, Check IJ, Hunter RL. Modification of acute focal ischemia in rabbits by poloxamer 188. Stroke 1989; 20: 1241-6
• 21 Robinson KA, Hunter RL, Stack JE, Hearn JA, Apiarian RP, Roubin GS. Inhibition of coronary arterial thrombosis in swine by infusion of Poloxamer 188. J Invest Cardiol 1990; 2: 9-20
• 22 Hunter RL, Bennett B, Check IJ. The effect of Poloxamer 188 on the rate of in vitro thrombolysis mediated by t-PA and streptokinase. Fibrinolysis 1990; 4: 117-23
• 23 Laki K. The polymerization of proteins: the action of thrombin on fibrinogen. Arch Biochem Biophys 1951; 32: 317-24
• 24 Clauss A. A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol 1957; 17: 237-46
• 25 Carr ME, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules 1978; 11: 46-50
• 26 Carr ME, Krishnamurti C, Alving BM. Effect of plasminogen activator inhibitor type 1 (PAI-1) on tissue plasminogen activator (TPA) induced fibrinolysis. Blood 1988; 72: 293a
• 27 Carr ME, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 1977; 16: 1-15
• 28 Carr ME. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen. Thromb Haemostas 1988; 5 9(3) 535-9
• 29 Carr ME, Hardin CL. Fibrin has larger pores when formed in the presence of erythrocytes. Am J Physiol 1987; 253: H1069-H1073
• 30 Carr ME, Hauge Y. Enhancement of erythrocyte washout from blood clots by pharmacologic manipulation of gel pore size and erythrocyte flexibility. Am J Physiol (Heart) 1990 in press
• 31 Carr ME, Powers PL. Effect of fibrin structure on t-PA induced dissolution of preformed plasma clots. Fibrinolysis 1990; 4 (Suppl 3) 124
• 32 Hymes AC, Robb HJ, Margulis RR. Influence of an inductrial surfactant (pluronic F-68) on human amniotic fluid embolism. Am J Obstet Gynecol 1970; 107: 1217-22
• 33 Witte S, Dirnberger P. Wirkungen von Protamin auf Fibrinogen in vivo und in vitro. Klin Wochenschr 1952; 385: 997
• 34 Cohen C, Slayter H, Goldstein L, Kucera J, Hall C. Polymorphism in fibrinogen aggregates. J Mol Biol 1966; 22: 385-6
• 35 Stewart GJ, Niewiarowski S. Nonenzymatic polymerization of fibrinogen by protamine sulfate. Biochim Biophys Acta 1969; 194: 462-9